Integrative multi-omic analysis reveals neurodevelopmental gene dysregulation in CIC-knockout and IDH1-mutant cells

J Pathol. 2022 Mar;256(3):297-309. doi: 10.1002/path.5835. Epub 2021 Dec 22.

Abstract

Capicua (CIC)'s transcriptional repressor function is implicated in neurodevelopment and in oligodendroglioma (ODG) aetiology. However, CIC's role in these contexts remains obscure, primarily from our currently limited knowledge regarding its biological functions. Moreover, CIC mutations in ODG invariably co-occur with a neomorphic IDH1/2 mutation, yet the functional relationship between these two genetic events is unknown. Here, we analysed models derived from an E6/E7/hTERT-immortalized (i.e. p53- and RB-deficient) normal human astrocyte cell line. To examine the consequences of CIC loss, we compared transcriptomic and epigenomic profiles between CIC wild-type and knockout cell lines, with and without mutant IDH1 expression. Our analyses revealed dysregulation of neurodevelopmental genes in association with CIC loss. CIC ChIP-seq was also performed to expand upon the currently limited ensemble of known CIC target genes. Among the newly identified direct CIC target genes were EPHA2 and ID1, whose functions are linked to neurodevelopment and the tumourigenicity of in vivo glioma tumour models. NFIA, a known mediator of gliogenesis, was discovered to be uniquely overexpressed in CIC-knockout cells expressing mutant IDH1-R132H protein. These results identify neurodevelopment and specific genes within this context as candidate targets through which CIC alterations may contribute to the progression of IDH-mutant gliomas. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Keywords: capicua transcriptional repressor; epigenomics; neomorphic IDH mutation; transcriptomics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Astrocytes / enzymology*
  • Astrocytes / pathology
  • Brain Neoplasms / enzymology
  • Brain Neoplasms / genetics
  • Brain Neoplasms / pathology
  • Cell Line, Transformed
  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / metabolism
  • Cell Transformation, Neoplastic / pathology
  • DNA Methylation
  • Epigenesis, Genetic
  • Epigenome*
  • Epigenomics*
  • Gene Expression Profiling*
  • Gene Expression Regulation, Developmental
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques
  • Humans
  • Isocitrate Dehydrogenase / genetics*
  • Isocitrate Dehydrogenase / metabolism
  • Mutation*
  • NFI Transcription Factors / genetics
  • NFI Transcription Factors / metabolism
  • Oligodendroglioma / enzymology
  • Oligodendroglioma / genetics
  • Oligodendroglioma / pathology
  • Receptor, EphA2 / genetics
  • Receptor, EphA2 / metabolism
  • Repressor Proteins / deficiency
  • Repressor Proteins / genetics*
  • Transcriptome*

Substances

  • CIC protein, human
  • EPHA2 protein, human
  • NFI Transcription Factors
  • NFIA protein, human
  • Repressor Proteins
  • Isocitrate Dehydrogenase
  • IDH1 protein, human
  • Receptor, EphA2